These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 30512144

  • 1. [Not Available].
    Strandberg K.
    Lakartidningen; 2018 Dec 04; 115():. PubMed ID: 30512144
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Measurement of Non-Vitamin K Antagonist Oral Anticoagulants in Patient Plasma Using Heptest-STAT Coagulation Method.
    Du S, Harenberg J, Krämer S, Krämer R, Wehling M, Weiss C.
    Ther Drug Monit; 2015 Jun 04; 37(3):375-80. PubMed ID: 25525760
    [Abstract] [Full Text] [Related]

  • 4. Direct oral anticoagulants and heparins: laboratory values and pitfalls in 'bridging therapy'.
    Eller T, Flieder T, Fox V, Gripp T, Dittrich M, Kuhn J, Alban S, Knabbe C, Birschmann I.
    Eur J Cardiothorac Surg; 2017 Apr 01; 51(4):624-632. PubMed ID: 28043992
    [Abstract] [Full Text] [Related]

  • 5. Laboratory Monitoring of Non-Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation: A Review.
    Eikelboom JW, Quinlan DJ, Hirsh J, Connolly SJ, Weitz JI.
    JAMA Cardiol; 2017 May 01; 2(5):566-574. PubMed ID: 28355459
    [Abstract] [Full Text] [Related]

  • 6. Multianalyte Determination of NOACs Using LC-MS/MS and Comparison with Functional Coagulation Assays.
    Slavik L, Lukes J, Friedecky D, Zhanelova M, Nemcova M, Ulehlova J, Prochazkova J, Hlusi A, Palova M, Vaclavik J.
    Clin Lab; 2018 Oct 01; 64(10):1611-1621. PubMed ID: 30336535
    [Abstract] [Full Text] [Related]

  • 7. [Monitoring options and reversal agents for oral anticoagulants].
    Thorup SB, Husted SE, Vang ML.
    Ugeskr Laeger; 2014 Apr 28; 176(9):. PubMed ID: 25096568
    [Abstract] [Full Text] [Related]

  • 8. Laboratory monitoring of the non-vitamin K oral anticoagulants.
    Blann AD, Lip GY.
    J Am Coll Cardiol; 2014 Sep 16; 64(11):1140-2. PubMed ID: 25212649
    [No Abstract] [Full Text] [Related]

  • 9. Direct Oral Anticoagulants (DOACs) in the Laboratory: 2015 Review.
    Adcock DM, Gosselin R.
    Thromb Res; 2015 Jul 16; 136(1):7-12. PubMed ID: 25981138
    [Abstract] [Full Text] [Related]

  • 10. Laboratory measurement of the direct oral anticoagulants.
    Dale BJ, Chan NC, Eikelboom JW.
    Br J Haematol; 2016 Feb 16; 172(3):315-36. PubMed ID: 26492202
    [Abstract] [Full Text] [Related]

  • 11. The effect of the direct factor Xa inhibitors apixaban and rivaroxaban on haemostasis tests: a comprehensive assessment using in vitro and ex vivo samples.
    Bonar R, Favaloro EJ, Mohammed S, Ahuja M, Pasalic L, Sioufi J, Marsden K.
    Pathology; 2016 Jan 16; 48(1):60-71. PubMed ID: 27020211
    [Abstract] [Full Text] [Related]

  • 12. [Large studies of NOAC shows good and safe stroke protection].
    Hijazi Z, Oldgren J.
    Lakartidningen; 2015 Sep 08; 112():. PubMed ID: 26348046
    [No Abstract] [Full Text] [Related]

  • 13. Interlaboratory variability in the measurement of direct oral anticoagulants: results from the external quality assessment scheme.
    Tripodi A, Chantarangkul V, Legnani C, Testa S, Tosetto A.
    J Thromb Haemost; 2018 Mar 08; 16(3):565-570. PubMed ID: 29322630
    [Abstract] [Full Text] [Related]

  • 14. Quantification of Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in Human Serum by UHPLC-MS/MS-Method Development, Validation, and Application.
    Lindahl S, Dyrkorn R, Spigset O, Hegstad S.
    Ther Drug Monit; 2018 Jun 08; 40(3):369-376. PubMed ID: 29578938
    [Abstract] [Full Text] [Related]

  • 15. Point-of-Care Testing of Coagulation in Patients Treated With Non-Vitamin K Antagonist Oral Anticoagulants.
    Ebner M, Peter A, Spencer C, Härtig F, Birschmann I, Kuhn J, Wolf M, Winter N, Russo F, Zuern CS, Blumenstock G, Ziemann U, Poli S.
    Stroke; 2015 Oct 08; 46(10):2741-7. PubMed ID: 26272385
    [Abstract] [Full Text] [Related]

  • 16. Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants.
    Ebner M, Birschmann I, Peter A, Spencer C, Härtig F, Kuhn J, Blumenstock G, Zuern CS, Ziemann U, Poli S.
    Crit Care; 2017 Feb 15; 21(1):32. PubMed ID: 28196509
    [Abstract] [Full Text] [Related]

  • 17. Assessment of direct oral anticoagulant assay use in clinical practice.
    Gu TM, Garcia DA, Sabath DE.
    J Thromb Thrombolysis; 2019 Apr 15; 47(3):403-408. PubMed ID: 30600427
    [Abstract] [Full Text] [Related]

  • 18. Measurement of apixaban concentrations in real‑world clinical and laboratory settings: the first Polish experience.
    Góralczyk T, Papuga-Szela E, Żuk J, Undas A.
    Pol Arch Intern Med; 2018 May 30; 128(5):324-326. PubMed ID: 29768395
    [No Abstract] [Full Text] [Related]

  • 19. Measurement of apixaban, dabigatran, edoxaban and rivaroxaban in human plasma using automated online solid-phase extraction combined with ultra-performance liquid chromatography-tandem mass spectrometry and its comparison with coagulation assays.
    Kuhn J, Gripp T, Flieder T, Hammerschmidt A, Hendig D, Faust I, Knabbe C, Birschmann I.
    Clin Chim Acta; 2018 Nov 30; 486():347-356. PubMed ID: 30114406
    [No Abstract] [Full Text] [Related]

  • 20. Clinical Pharmacology of Oral Anticoagulants in Patients with Kidney Disease.
    Jain N, Reilly RF.
    Clin J Am Soc Nephrol; 2019 Feb 07; 14(2):278-287. PubMed ID: 29802125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.